Investor profile
Tekla Capital Management has backed 4 European tech companies across 5 funding rounds between 2018 and 2023, joining rounds totalling €359M. Most active in Healthtech. Data as of 7 Aug 2026.
Also recorded as: Tekla Capital Investment LLC
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Quell Therapeutics | UK | 1 | €138M |
| Amolyt Pharma | France | 1 | €129M |
| Oculis | Switzerland | 2 | €61M |
| Priothera Limited | Ireland | 1 | €30M |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Quell Therapeutics | Series B | €138M | 2021-11 |
| Amolyt Pharma | Series C | €129M | 2023-01 |
| Oculis | Series C | €47M | 2021-05 |
| Priothera Limited |
| Series A |
| €30M |
| 2020-10 |
| Oculis | Series B | €14M | 2019-01 |
